Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae

JOURNAL ARTICLE published 2003 in Expert Opinion on Emerging Drugs

Authors: George G Zhanel | Tamiko Hisanaga | Kim Nichol | Aleksandra Wierzbowski | Daryl J Hoban

Emerging drugs for endometriosis

JOURNAL ARTICLE published 2004 in Expert Opinion on Emerging Drugs

Authors: Luigi Fedele | Nicola Berlanda

Emerging therapies for cystic fibrosis lung disease

JOURNAL ARTICLE published December 2010 in Expert Opinion on Emerging Drugs

Authors: Hartmut Grasemann | Felix Ratjen

Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease

JOURNAL ARTICLE published September 2007 in Expert Opinion on Emerging Drugs

Authors: Mario Cozzolino | Diego Brancaccio

Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy

JOURNAL ARTICLE published May 2006 in Expert Opinion on Emerging Drugs

Authors: Joel B Epstein | Gary D Klasser

Emerging drugs for the acute treatment of relapses in adult neuromyelitis optica spectrum disorder patients

JOURNAL ARTICLE published 2 January 2022 in Expert Opinion on Emerging Drugs

Authors: Edgar Carnero Contentti | Pablo A. López | Juan I. Rojas

Emerging drugs for the treatment of hypercholesterolemia

JOURNAL ARTICLE published 2 January 2019 in Expert Opinion on Emerging Drugs

Authors: Marilisa Bove | Arrigo F.G. Cicero | Claudio Borghi

Emerging drugs in cutaneous T-cell lymphomas

JOURNAL ARTICLE published May 2005 in Expert Opinion on Emerging Drugs

Authors: Reinhard Dummer

Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer’s disease: do we need new inhibitors?

JOURNAL ARTICLE published November 2005 in Expert Opinion on Emerging Drugs

Authors: David H Small

Emerging drugs for actinic keratosis

JOURNAL ARTICLE published December 2010 in Expert Opinion on Emerging Drugs

Authors: Martina Ulrich | Ulrike Drecoll | Eggert Stockfleth

Treatment of Type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors

JOURNAL ARTICLE published 2004 in Expert Opinion on Emerging Drugs

Authors: Jens Juul Holst

Advances in emerging drugs for the treatment of neuroblastoma

JOURNAL ARTICLE published 2 January 2017 in Expert Opinion on Emerging Drugs

Authors: Pablo Berlanga | Adela Cañete | Victoria Castel

Emerging drugs for the treatment of major depressive disorder

JOURNAL ARTICLE published 3 July 2022 in Expert Opinion on Emerging Drugs

Authors: Jennifer Hong | Darian Vernon | Jelena Kunovac | Stephen Stahl

Emerging drugs for the treatment of benign prostatic obstruction

JOURNAL ARTICLE published June 2010 in Expert Opinion on Emerging Drugs

Authors: Hashim Hashim | Paul Abrams

Emerging drugs for idiopathic pulmonary fibrosis

JOURNAL ARTICLE published November 2005 in Expert Opinion on Emerging Drugs

Authors: Victor J Thannickal | Kevin R Flaherty | Robert C Hyzy | Joseph P Lynch

Emerging drugs for functional dyspepsia

JOURNAL ARTICLE published June 2011 in Expert Opinion on Emerging Drugs

Authors: Jan Tack | Pieter Janssen

Emerging protein kinase inhibitors for treating pancreatic cancer

JOURNAL ARTICLE published 2 January 2017 in Expert Opinion on Emerging Drugs

Authors: Junji Furuse | Fumio Nagashima

Emerging drugs for the treatment of bone metastasis

JOURNAL ARTICLE published 2 October 2015 in Expert Opinion on Emerging Drugs

Authors: Francesco Pantano | Michele Iuliani | Alice Zoccoli | Marco Fioramonti | Delia De Lisi | Iacopo Fioroni | Giulia Ribelli | Matteo Santoni | Bruno Vincenzi | Giuseppe Tonini | Daniele Santini

Treatments in the COVID-19 pandemic: an update on clinical trials

JOURNAL ARTICLE published 2 April 2020 in Expert Opinion on Emerging Drugs

Authors: Yanyi Tao | Liang V. Tang | Yu Hu

Emerging drugs for attention-deficit/hyperactivity disorder

JOURNAL ARTICLE published September 2007 in Expert Opinion on Emerging Drugs

Authors: Richard H Weisler